RU2021105345A - A NEW CYCLIC DINUCLEOTIDE DERIVATIVE AND ITS ANTIBODY-DRUG CONJUGATE - Google Patents
A NEW CYCLIC DINUCLEOTIDE DERIVATIVE AND ITS ANTIBODY-DRUG CONJUGATE Download PDFInfo
- Publication number
- RU2021105345A RU2021105345A RU2021105345A RU2021105345A RU2021105345A RU 2021105345 A RU2021105345 A RU 2021105345A RU 2021105345 A RU2021105345 A RU 2021105345A RU 2021105345 A RU2021105345 A RU 2021105345A RU 2021105345 A RU2021105345 A RU 2021105345A
- Authority
- RU
- Russia
- Prior art keywords
- antibody
- drug conjugate
- group
- paragraphs
- antibody drug
- Prior art date
Links
- 239000000611 antibody drug conjugate Substances 0.000 title claims 74
- 108091008116 antibody drug conjugates Proteins 0.000 title claims 74
- 108090001123 antibodies Proteins 0.000 claims 59
- 102000004965 antibodies Human genes 0.000 claims 59
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 22
- 239000000427 antigen Substances 0.000 claims 18
- 108091007172 antigens Proteins 0.000 claims 18
- 102000038129 antigens Human genes 0.000 claims 18
- 125000003275 alpha amino acid group Chemical group 0.000 claims 15
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 15
- 125000004430 oxygen atoms Chemical group O* 0.000 claims 13
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 12
- 150000004676 glycans Chemical class 0.000 claims 12
- 125000005843 halogen group Chemical group 0.000 claims 10
- 229910052757 nitrogen Inorganic materials 0.000 claims 8
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims 8
- 229910052717 sulfur Inorganic materials 0.000 claims 7
- 125000004434 sulfur atoms Chemical group 0.000 claims 7
- 201000011510 cancer Diseases 0.000 claims 6
- 229910052731 fluorine Inorganic materials 0.000 claims 6
- 125000001153 fluoro group Chemical group F* 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 5
- 229940079593 drugs Drugs 0.000 claims 5
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 4
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 4
- 206010051066 Gastrointestinal stromal tumour Diseases 0.000 claims 4
- 125000000539 amino acid group Chemical group 0.000 claims 4
- 201000011243 gastrointestinal stromal tumor Diseases 0.000 claims 4
- 201000010915 glioblastoma multiforme Diseases 0.000 claims 4
- 238000006467 substitution reaction Methods 0.000 claims 4
- 239000002246 antineoplastic agent Substances 0.000 claims 3
- 235000018102 proteins Nutrition 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 2
- -1 2-hydroxyacetylaminomethyl group Chemical group 0.000 claims 2
- 206010004593 Bile duct cancer Diseases 0.000 claims 2
- 206010005003 Bladder cancer Diseases 0.000 claims 2
- 208000003174 Brain Neoplasms Diseases 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 206010008342 Cervix carcinoma Diseases 0.000 claims 2
- 206010014733 Endometrial cancer Diseases 0.000 claims 2
- 206010017758 Gastric cancer Diseases 0.000 claims 2
- 206010024324 Leukaemias Diseases 0.000 claims 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 2
- 206010025323 Lymphomas Diseases 0.000 claims 2
- 206010025598 Malignant hydatidiform mole Diseases 0.000 claims 2
- 206010025650 Malignant melanoma Diseases 0.000 claims 2
- 206010027406 Mesothelioma Diseases 0.000 claims 2
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 2
- 206010025310 Other lymphomas Diseases 0.000 claims 2
- 206010033128 Ovarian cancer Diseases 0.000 claims 2
- 208000008443 Pancreatic Carcinoma Diseases 0.000 claims 2
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 2
- 208000007452 Plasmacytoma Diseases 0.000 claims 2
- 206010060862 Prostate cancer Diseases 0.000 claims 2
- 206010038389 Renal cancer Diseases 0.000 claims 2
- 206010039491 Sarcoma Diseases 0.000 claims 2
- 206010041823 Squamous cell carcinoma Diseases 0.000 claims 2
- 206010057644 Testis cancer Diseases 0.000 claims 2
- 201000005188 adrenal gland cancer Diseases 0.000 claims 2
- 239000000556 agonist Substances 0.000 claims 2
- 235000004279 alanine Nutrition 0.000 claims 2
- 125000003295 alanine group Chemical class N[C@@H](C)C(=O)* 0.000 claims 2
- 201000010881 cervical cancer Diseases 0.000 claims 2
- 201000011231 colorectal cancer Diseases 0.000 claims 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 2
- 201000004101 esophageal cancer Diseases 0.000 claims 2
- 201000010175 gallbladder cancer Diseases 0.000 claims 2
- 201000010982 kidney cancer Diseases 0.000 claims 2
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 claims 2
- 201000007270 liver cancer Diseases 0.000 claims 2
- 201000005202 lung cancer Diseases 0.000 claims 2
- 201000001441 melanoma Diseases 0.000 claims 2
- 201000000050 myeloid neoplasm Diseases 0.000 claims 2
- 201000002528 pancreatic cancer Diseases 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 201000008824 placental choriocarcinoma Diseases 0.000 claims 2
- 201000011549 stomach cancer Diseases 0.000 claims 2
- 201000003120 testicular cancer Diseases 0.000 claims 2
- 201000005161 thyroid carcinoma Diseases 0.000 claims 2
- 201000005112 urinary bladder cancer Diseases 0.000 claims 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 1
- 102100010289 CITED1 Human genes 0.000 claims 1
- 101710015493 CITED1 Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 235000001014 amino acid Nutrition 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000002494 anti-cea Effects 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000000562 conjugate Substances 0.000 claims 1
- 230000000875 corresponding Effects 0.000 claims 1
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 claims 1
- DMJZZSLVPSMWCS-UHFFFAOYSA-N diborane Chemical group B1[H]B[H]1 DMJZZSLVPSMWCS-UHFFFAOYSA-N 0.000 claims 1
- 238000005755 formation reaction Methods 0.000 claims 1
- 238000010353 genetic engineering Methods 0.000 claims 1
- 101700077358 gmh1 Proteins 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 229920001481 poly(stearyl methacrylate) Polymers 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 150000003568 thioethers Chemical class 0.000 claims 1
Claims (219)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018-167369 | 2018-09-06 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2023132320A Division RU2023132320A (en) | 2018-09-06 | 2019-09-06 | A NEW CYCLIC DINUCLEOTIDE DERIVATIVE AND ITS ANTIBODY-DRUG CONJUGATE |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2021105345A true RU2021105345A (en) | 2022-10-06 |
RU2809547C2 RU2809547C2 (en) | 2023-12-12 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10787480B2 (en) | Cytotoxic peptides and conjugates thereof | |
JP7042291B2 (en) | Its application to linkers and ADCs | |
RU2503687C2 (en) | Stitching reagents and their use | |
JP7033677B2 (en) | Method for preparing cyclic depsipeptide | |
RU2015142093A (en) | AMATOXINE DERIVATIVES | |
CA2951368A1 (en) | Auristatin derivatives and conjugates thereof | |
US11730822B2 (en) | Process for the preparation of glucuronide drug-linkers and intermediates thereof | |
CN108201625B (en) | Linker drugs and antibody drug complexes comprising the same | |
RU2021105345A (en) | A NEW CYCLIC DINUCLEOTIDE DERIVATIVE AND ITS ANTIBODY-DRUG CONJUGATE | |
AU2018317611B2 (en) | Non-natural amatoxin-type antibody conjugate | |
EP3717016A1 (en) | Process for the preparation of drug linker compounds | |
WO2024041541A1 (en) | A novel thiol reductant, method and use thereof | |
WO2024041543A1 (en) | A method of preparing an antibody with thiol group site-specific modifications and use of tcep | |
WO2024041545A1 (en) | A novel thiol reductant, preparation method and use thereof | |
WO2024041542A1 (en) | A method for programmatically managing antibody disulfide bonds site-specific modification | |
WO2020167855A1 (en) | Processes and compounds | |
WO2024041544A1 (en) | A method of preparing an antibody with site-specific modifications | |
RU2777160C2 (en) | Improved method for synthesis of linker-drug vc-seco-duba | |
EP3538510B1 (en) | Process for the preparation of mono-protected alpha,omega-diamino alkanes | |
CN111556870B (en) | Improved method for synthesizing linker-drug VC-SECO-DUBA | |
RU2019111768A (en) | ANTI-CANCER AGENTS AND THEIR PREPARATION | |
RU2023132320A (en) | A NEW CYCLIC DINUCLEOTIDE DERIVATIVE AND ITS ANTIBODY-DRUG CONJUGATE | |
RU2023127992A (en) | DNA-TOXIC DIMER COMPOUND AND ITS CONJUGATE | |
WO2018045245A1 (en) | Cyclic peptide analogs and conjugates thereof | |
RU2013145314A (en) | AMATOXIN CONJUGATES WITH IMPROVED CONNECTIONS |